MA11.04 Updated Efficacy, Safety and Dosing Management of Poziotinib in Previously Treated EGFR and HER2 Exon 20 NSCLC Patients

Autor: Cornelissen, R., Garassino, M.C., Le, X., Clarke, J., Tchekmedyian, N., Goldman, J., Lebel, F., Bhat, G., Socinski, M.
Zdroj: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S173-S174
Databáze: ScienceDirect